Biogen Inc.

BIIB · Healthcare · · USD

197.95 USD

+0.00 (2.33%)

● Updated 2026-05-12 11:49 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score STRONG BUY Short-term (Swing)

/ 100

Technical 100

Trend & RS 81

Momentum 68

Fundamental (0%) 67

Macro 65

Liquidity 59

Component	Score	Weight
Technical	100.0	40%
Trend & RS	80.6	20%
Momentum	68.3	20%
Fundamental	66.7	0%
Macro	65.1	15%
Liquidity	59.4	5%

Trade Setup

Entry	197.95
Stop Loss	186.91 (5.6%)
Target 1 (1:1)	208.99 (+5.6%)
Target 2 (2:1)	220.03 (+11.2%)

ATR(14)	5.52 (2.8%)
Risk per Share	11.04
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	76.3	+1.05
Momentum	68.3	+0.73
Quality	52.1	+0.08
Composite	65.6

Quality Scores

Piotroski F-Score 6 /9 — Average

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✗

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	21.3	22.0	Inline
P/B Ratio	1.6	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

114.81

Market Price

197.95

Upside

-42.0%

Margin of Safety	-72.4%
Stage 1 PV (5yr FCF)	4,520,339,420
Terminal Value PV	12,429,320,070
Total Enterprise Value	16,949,659,490

Assumptions

Base FCF	1,098,420,157
Growth Rate (5yr)	2.0%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

52.88%

Full Kelly

26.44%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 82/100. Estimated win rate 65%, avg win 10.0%, avg loss 3.4%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

63.52

RSI(14)

2.9796

MACD

Relative Strength (RS) WEAKENING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↓ FALLING (-4.7% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (29d since high)
Sector Outperformance	+4.7% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAKENING: Losing momentum — the stock was performing well but is now falling behind the market.

Technical Indicators

Indicator	Value	Signal
Rsi	63.52	NEUTRAL
Macd	2.9796	BULLISH
Ma Cross	184.63 / 166.36	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	1.56x	HIGH

Key Levels

Level	Price
52-Week High	202.41
Bollinger Upper	198.22
SMA(200)	166.36
SMA(50)	184.63
SMA(20)	186.45
Current Price	197.95
Bollinger Lower	174.69
52-Week Low	119.18
ATR(14)	5.52

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

DISTRIBUTION A Confidence

75%

Buying Climax

Acc: 1.0 | Dist: 3.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-05-05	Normal	0.52x	Normal bar — no special VSA pattern
2026-05-06	Normal	0.65x	Normal bar — no special VSA pattern
2026-05-07	Normal	0.65x	Normal bar — no special VSA pattern
2026-05-08	Normal	0.82x	Normal bar — no special VSA pattern
2026-05-11	Normal	1.56x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	190.25	Above Kijun
Kijun-sen (26)	184.47	Base line
Senkou A	187.36	Leading span A
Senkou B	184.47	Leading span B
Cloud	184.47 – 187.36	Bullish (Green)
Price vs Cloud	197.95	Above Cloud
Chikou Span	172.34	Bullish
Alignment Score	4/4	BULLISH